<unk>  allograft vasculopathy (CAV) is characterized by concentric intimal proliferation leading to diffuse narrowing of the entire length of the epicardial vessel. Immune mediated processes are thought to be the biggest risk<unk>  driving the process of graft vessel narrowing. However, traditional risk<unk>  for coronary artery disease such as hyperlipidemia, diabetes mellitus, hypertension and smoking have been shown to play a considerable role in the pathogenesis of CAV.
Cardiac allograft vasculopathy risk factors
Cardiac allograft vasculopathy pathophysiology
Cardiac allograft vasculopathy epidemiology and demographics
Cardiac allograft vasculopathy medical therapy
Heart transplantation associated arrhythmias
Heart transplantation immunosuppressive therapy
Cardiac allograft vasculopathy laboratory findings
HIV associated nephropathy risk factors